337 studies found for:    "Thyroid Neoplasms"
Show Display Options
Rank Status Study
1 Completed Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
Conditions: Cancer of the Thyroid;   Neoplasms, Thyroid;   Thyroid Adenoma;   Thyroid Cancer;   Thyroid Carcinoma
Intervention:
2 Terminated Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
Conditions: Thyroid Neoplasm;   Thyroid Carcinoma;   Medullary Carcinoma
Intervention: Other: 18F-L-DOPA PET
3 Recruiting Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia
Conditions: Thyroid Neoplasms;   Thyroid Cancer
Intervention: Procedure: Histological investigation of the SN
4 Active, not recruiting The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
Conditions: Thyroid Nodule;   Thyroid Neoplasms;   Thyroid Cancer
Intervention:
5 Active, not recruiting Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Conditions: Thyroid Neoplasms;   Carcinoma;   Thyroid Cancer;   Metastatic Cancer
Intervention: Drug: Bevacizumab
6 Not yet recruiting PET Evaluation of Recurrent Differentiated Thyroid Cancer
Conditions: Thyroid Neoplasms;   Differentiated Thyroid Cancer
Intervention:
7 Completed
Has Results
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Conditions: Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage II Follicular Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Papillary Thyroid Cancer
Intervention: Drug: Bortezomib
8 Recruiting Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Conditions: Follicular Thyroid Cancer;   Insular Thyroid Cancer;   Papillary Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: dabrafenib;   Drug: trametinib;   Other: Correlative Studies
9 Recruiting Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
Conditions: Papillary Thyroid Cancer;   Follicular Thyroid Cancer;   Differentiated Thyroid Cancer
Intervention: Drug: SU011248, Sutent
10 Completed
Has Results
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
Conditions: Thyroid Cancer;   Differentiated Thyroid Carcinoma
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
11 Completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Conditions: Metastatic Differentiated Thyroid Cancer;   Metastatic Poorly Differentiated Thyroid Cancer;   Metastatic Anaplastic Thyroid Cancer;   Metastatic Medullary Thyroid Cancer
Intervention: Drug: sorafenib
12 Recruiting Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Conditions: Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node;   Metastatic Medullary Thyroid Cancer;   Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Drug: Ferumoxytol;   Device: lymphotrophic superparamagnetic nanoparticles (LSN MRI).
13 Completed Multicenter Study Differentiated Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention: Procedure: external beam radiotherapy
14 Completed Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention:
15 Completed Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma
Conditions: Thyroid Neoplasm;   Lymphatic Metastasis
Intervention: Procedure: prophylactic selective lateral neck dissection
16 Completed Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention: Drug: bispecific antibody and di-DTPA-131I
17 Completed Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
Condition: Thyroid Neoplasms
Intervention: Procedure: IMRT
18 Terminated Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Papillary Thyroid Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
19 Unknown  An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
Conditions: Thyroid Neoplasms;   Head and Neck Neoplasms
Interventions: Drug: C-PERT;   Drug: G-PERT
20 Active, not recruiting Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years